Silence Therapeutics
SLN
#6719
Rank
A$1.16 B
Marketcap
A$18.73
Share price
-0.22%
Change (1 day)
140.31%
Change (1 year)

EPS for Silence Therapeutics (SLN)

EPS in 2026 (TTM): A-$2.99

According to Silence Therapeutics's latest financial reports the company's current EPS (TTM) is A-$2.72. In 2025 the company made an earnings per share (EPS) of A-$2.64 a decrease over its 2024 EPS that were of A-$1.38.

EPS history for Silence Therapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.9913.16%
2025A-$2.6490.91%
2024A-$1.38-32.65%
2023A-$2.05-5.77%
2022A-$2.18-13.03%
2021A-$2.5010.23%
2020A-$2.2758.5%
2019A-$1.432.94%
2018A-$1.39969.59%
2017A-$0.13-79.18%
2016A-$0.63-3.11%
2015A-$0.65-55%
2014A-$1.433.83%
2013A-$1.38-84.88%
2012A-$9.14134.19%
2011A-$3.90-61.8%
2010A-$10.21-45.65%
2009A-$18.79-1.16%
2008A-$19.014.29%
2007A-$18.2310.54%
2006A-$16.49-22.29%
2005A-$21.22-57.32%
2004A-$49.7239.1%
2003A-$35.7470.67%
2002A-$20.94-25.17%
2001A-$27.995.29%
2000A-$26.58-24.54%
1999A-$35.2226.7%
1998A-$27.80-11.73%
1997A-$31.5072.24%
1996A-$18.29